
Prostate cancer is the most common cancer in American men. The good news is, if prostate cancer is detected early — when it’s still confined to the prostate gland — there is an excellent chance of successful treatment with minimal or short-term side effects.
The Center for Prostate Health is dedicated to providing men with education, screening, intervention and expert treatment of prostate cancer. The center is staffed by radiation oncologists, medical oncologists and urologists who specialize in prostate health.
The Center for Prostate Health offers the most advanced cancer therapy technology and treatment options, including robotic-assisted surgical techniques, image-guided radiation therapy (IGRT) and intensity modulated radiation therapy (IMRT), as well as options in medical oncology (chemotherapy).
A number of surgical options are available and are tailored to the needs of each individual. They include robotic-assisted laparoscopic radical prostatectomy, nerve-sparing robotic-assisted laparoscopic radical prostatectomy, open prostatectomy, nerve-sparing open prostatectomy and cryosurgery.
Since many tumors are deep in the body, their location must be “mapped” using imaging, so radiation therapy can be delivered accurately and effectively. Along with radioactive seed implants (standard brachytherapy), IMRT and IGRT technology allows us to target and deliver the most effective radiation treatments for prostate cancer.
Men facing a diagnosis of prostate cancer may worry about caring for their families, keeping their jobs, or continuing daily activities. Concerns about treatments and managing side effects, relationships and emotions are also common. Center for Prostate Health team members work together to address issues such as patient education, help with treatment decision-making, coordination of care and emotional support.
The Prostate Cancer Support Group meets once each month in a relaxed setting for learning, obtaining the latest information on treatment from health professionals and gaining support from group members who have also been diagnosed with prostate cancer.